Delivery Order SPE2DB22D2211-SPE2DB24FMTZ7
- Not listed
- This federal contract award, valued at $2,912.79, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The delivery order is for the supply of 4560073945 - MUPIROCIN 2% CREAM 15GM, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2023 and is structured as a firm fixed price delivery order. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major...
- This federal contract award, valued at $1,970.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MUPIROCIN 2% CREAM 15GM, a pharmaceutical product, and is a firm fixed-price delivery order with a completion date of May 9, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $1,167.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of MUPIROCIN 2% CREAM 15GM, a topical antibiotic medication. The contract has an ultimate completion date of July 8, 2025 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
- This federal contract award, valued at $2,310.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MUPIROCIN 2% CREAM 30GM, a topical antibiotic medication, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the delivery of MUPIROCIN 2% CREAM 15GM. The award has a ceiling value of $1,574.36 and is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of May 9, 2023. This contract is not designated as a set-aside and was awarded competitively. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,194.51 firm fixed-price delivery order is for MUPIROCIN 2% OINTMENT 22GM, a pharmaceutical product. The award has an ultimate completion date of January 30, 2024. Amerisourcebergen Drug Corp, the prime contractor, is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to...
- This federal contract award is for the delivery of MUPIROCIN 2% CREAM 15GM to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract has a firm fixed price of $1,066.68 and a completion date of May 3, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MUPIROCIN 2% CREAM 15GM, a pharmaceutical product, with a ceiling value of $1,564.08 and a period of performance through June 13, 2025. The contract is not set-aside and is awarded as a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant...
- This contract award is for the delivery of MUPIROCIN 2% CREAM 15GM to the Defense Logistics Agency (DLA). The award, valued at $3,968.84, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of MUPIROCIN 2% CREAM 15GM, a pharmaceutical product, with a ceiling value of $1,851.56 and a performance period ending on May 30, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMTZ7Delivery Order
This federal contract award, valued at $3,057.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MUPIROCIN 2% CREAM 15GM, a pharmaceutical product, with a completion date of February 9, 2024. The contract is a Delivery Order under a Firm Fixed Price contract type. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor, and no major subcontractors are mentioned. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds significant Indefinite Delivery Contracts with the DLA Troop Support Medical, valued up to $999,999,999, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000, to provide a comprehensive range of pharmaceutical products and medical supplies to support various federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 2/8/24 |